BMYMP Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 geg. 2024 @ 16:46):

Stats
Dzisiejszy wolumen	2.00
Średni wolumen	1.00
Kapitalizacja rynkowa	83.29B
EPS	$0 ( 2024-05-15 )
Następna data zysków	( $0 ) 2024-07-26
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	3 288.89
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-01	Poole Ahn Amanda	Buy	0	Common Stock, $0.10 par value
2024-01-01	Poole Ahn Amanda	Sell	3 214	Market Share Units
2024-01-01	Poole Ahn Amanda	Sell	4 822	Performance Shares
2023-12-31	Yale Phyllis R	Buy	658	Deferred Share Units
2023-12-31	Storch Gerald L	Buy	706	Deferred Share Units

INSIDER POWER
-20.03
Last 94 transactions
Buy: 132 368 \| Sell: 222 964

Bristol-Myers Squibb Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bristol-Myers Squibb Finanse

Annual	2023
Przychody:	$45.01B
Zysk brutto:	$34.31B (76.24 %)
EPS:	$3.88

FY	2023
Przychody:	$45.01B
Zysk brutto:	$34.31B (76.24 %)
EPS:	$3.88

FY	2022
Przychody:	$46.16B
Zysk brutto:	$36.02B (78.04 %)
EPS:	$2.97

FY	2021
Przychody:	$46.39B
Zysk brutto:	$36.45B (78.57 %)
EPS:	$4.26

Financial Reports:

No articles found.

Bristol-Myers Squibb Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bristol-Myers Squibb

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.